JOJeanne Oiticica

Jeanne Oiticica

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jeanne Oiticica has a total of 213 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Proteomic Signatures of Noise‐Induced Hearing Loss in the Mouse Cochlea

    by Ana Carla Batissoco, Danillo Alencar‐Coutinho, Ana Carolina Ferreira‐Scatone, Stella Diogo‐Cavassana, Jeanne Oiticica, Karina Lezirovitz, Ricardo Ferreira Bento

    Hearing loss affects over 1.5 billion people worldwide and has substantial social, educational, and economic consequences. Although genetic studies have identified numerous hearing‐loss‐associated genes, the molecular changes accompanying noise‐induced hearing loss (NIHL) remain incompletely understood. We characterized the adult mouse cochlear proteome following damaging noise exposure using nano‐LC–MS/MS and an integrative bioinformatics workflow. Comparative profiling of normal‐hearing and NIHL cochleae identified 1742 proteins and an 80‐protein NIHL‐associated signature comprising 49 quantitatively defined differentially abundant proteins and 31 condition‐specific proteins. These proteins were organized into five functional groups encompassing metabolic and mitochondrial function, protein synthesis and ribonucleoprotein complexes, structural and synaptic organization, cell polarity and cytoskeletal remodeling, and regulatory and stress‐responsive functions. Representative alterations included reduced HSPA9, a mitochondrial chaperone involved in protein homeostasis; changes in the RNA‐associated proteins PRMT1 and CIRBP; reduced HAPLN1, associated with extracellular matrix organization; and altered MAP2K2, a signaling protein related to cell polarity; and increased SYNJ2. Comparison with an independent cochlear proteomic data set identified 39 of the 80 proteins as dysregulated, with 22 showing concordant directional changes. Single‐cell transcriptomic mapping provided cellular context for 74 of the 80 protein‐associated genes, while human genetic and disease annotations supported the prioritization of selected proteins associated with hearing or ear phenotypes. Together, these findings define a proteomic landscape of the noise‐exposed cochlea and identify molecular candidates and cellular processes for further investigation of NIHL.

  • Open Access

    Efficacy of donepezil in patients with chronic tinnitus

    by Elaine Miwa Watanabe, Laura G.E. Vasconcelos, Maria F. Bonadia-Moraes, Fatima T. Husain, Nilo J.C. Duarte, Jeanne Oiticica

  • Open Access

    Genetic Landscape of Hearing Loss in Brazilian Patients Reveals Population‐Specific Variants and Clinical Correlations

    by Stella Diogo‐Cavassana, Danillo Alencar‐Coutinho, Rafaella Abreu‐Oberhuber, Maria Eduarda Paramo‐Neto, Jeanne Oiticica, Ricardo Ferreira Bento, Ana Carla Batissoco, Karina Lezirovitz

    Hearing loss (HL) is the most prevalent sensory disorder globally and a major public health challenge in Brazil, affecting over 1.5 million individuals. While over 150 HL‐associated genes have been identified, the genetic architecture in underrepresented populations remains poorly defined, often limiting diagnostic yield and precision medicine. We assessed the diagnostic performance of a comprehensive 218‐gene HL panel in 99 Brazilian probands (78 non‐syndromic; 21 syndromic) who had previously tested negative for GJB2/GJB6 (DFNB1) and MT‐RNR1 (m.1555A>G) and did not have ear malformations. Targeted next‐generation sequencing was followed by variant interpretation according to ACMG/AMP guidelines, segregation analysis, and longitudinal phenotypic re‐evaluation. Integration of Brazil‐specific allele‐frequency data was used to refine variant classification. A molecular diagnosis or a candidate variant was identified in 61 probands, yielding an overall diagnostic yield of 43%–62%, depending on classification stringency. We identified 19 novel variants across 15 genes, with MYO7A and MYO15A as the most frequently implicated. Notably, 10.4% of patients initially diagnosed with non‐syndromic HL carried pathogenic or likely pathogenic variants in syndromic genes ( PEX6, BSND, USH1C , and WFS1 ), necessitating clinical reclassification. Segregation analysis and phenotypic reassessment further enabled the reclassification of three variants of uncertain significance (VUS). In syndromic cases, a molecular diagnosis was established in 41% of cases, including Usher, Waardenburg, Branchio‐oto‐renal, and Bartter syndromes. This first large‐scale clinical genetic evaluation of hearing loss in Brazil demonstrates that comprehensive gene panels incorporating population‐specific data significantly improve diagnostic accuracy. Our findings broaden the mutational landscape of HL‐associated genes, reinforce the value of integrated genetic approaches for underrepresented populations, and underscore their direct impact on patient care and clinical management.

  • Open Access

    A Structural Variant in the 5' Regulatory Region of DIAPH3 Segregates with Postlingual Hearing Loss and Auditory Neuropathy in a Multigenerational Brazilian Family

    by Karina Lezirovitz, Danillo Alencar-Coutinho, Stella Diogo-Cavassana, Rafaella Abreu-Oberhuber, Juliana Sampaio-Silva, Maria Eduarda Paramo-Neto, Regina Célia Mingroni-Netto, Carlos Kazuo Taguchi, Ronaldo Carvalho Santos-Junior, Ana Carla Batissoco, et al.

    Hearing loss is genetically diverse, as it is caused by alterations in many genes and diverse inheritance patterns. While most causative variants are found in coding regions, noncoding regulatory variants can alter gene expression and may not be detected by standard exome sequencing analysis. To identify the genetic cause of autosomal dominant postlingual hearing loss in a large Brazilian family with 39 affected individuals and to describe their clinical features. Comprehensive audiological and imaging evaluations were conducted. Whole-exome sequencing on four affected subjects, supplemented by structural-variant analysis, identified a candidate variant later confirmed by quantitative polymerase chain reaction (qPCR), PCR, and Sanger sequencing. Audiological testing of 61 relatives identified 31 individuals with progressive sensorineural hearing loss or auditory neuropathy linked to autosomal dominant inheritance. Genetic analysis revealed a DIAPH3 5'UTR deletion-insertion (c.-216_-46delinsAAGAA) that perfectly cosegregated with this specific phenotype. Notably, eight other affected relatives exhibited different clinical forms of hearing loss but did not carry the DIAPH3 variant, suggesting separate underlying causes for their symptoms. Identification of this regulatory structural variant supports the role of DIAPH3 in the etiological diagnosis of postlingual hearing loss and auditory neuropathy, with direct implications for genetic counseling and clinical management.

  • Open Access

    Translation and validation of the Tinnitus Primary Function Questionnaire into Brazilian Portuguese

    by Patrícia Perez Coradini, Sabrina Nuñes Gonçalves, Jeanne Oiticica


  • Open Access

    Hearing aid effectiveness on patients with chronic tinnitus and associated hearing loss

    by Patricia Simonetti, Laura Garcia Vasconcelos, Mara Rocha Gândara, Karina Lezirovitz, Ítalo Roberto Torres de Medeiros, Jeanne Oiticica


  • Evaluating the efficacy of hearing aids for tinnitus therapy – A Positron emission tomography study

    by Patricia Simonetti, Carla Rachel Ono, Camila de Godoi Carneiro, Rafay Ali Khan, Somayeh Shahsavarani, Fatima T. Husain, Jeanne Oiticica


  • Open Access

    Corrigendum to: NCOA3 identified as a new candidate to explain autosomal dominant progressive hearing loss

    by R Salazar-Silva, Vitor Lima Goes Dantas, Leandro Ucela Alves, Ana Carla Batissoco, Jeanne Oiticica, Elizabeth A Lawrence, Abdelwahab Kawafi, Yushi Yang, Fernanda Stávale Nicastro, Beatriz Caiuby Novaes, et al.

    In the originally published version of this manuscript, the Wellcome Trust funding was omitted. The funding section should mention Wellcome Trust grant number 108907/Z/15/Z. This error has been corrected online.


  • Molecular and genetic characterization of a large Brazilian cohort presenting hearing loss

    by Ana Carla Batissoco, Vinicius Pedroso-Campos, Eliete Pardono, Juliana Sampaio-Silva, Cindy Yukimi Sonoda, Gleiciele Alice Vieira-Silva, Estefany Uchoa da Silva de Oliveira Longati, Diego Mariano, Ana Cristina Hiromi Hoshino, Robinson Koji Tsuji, et al.

    Hearing loss is one of the most common sensory defects, affecting 5.5% of the worldwide population and significantly impacting health and social life. It is mainly attributed to genetic causes, but their relative contribution reflects the geographical region’s socio-economic development. Extreme genetic heterogeneity with hundreds of deafness genes involved poses challenges for molecular diagnosis. Here we report the investigation of 542 hearing-impaired subjects from all Brazilian regions to search for genetic causes. Biallelic GJB2/GJB6 causative variants were identified in 12.9% (the lowest frequency was found in the Northern region, 7.7%), 0.4% carried GJB2 dominant variants, and 0.6% had the m.1555A > G variant (one aminoglycoside-related). In addition, other genetic screenings, employed in selected probands according to clinical presentation and presumptive inheritance patterns, identified causative variants in 2.4%. Ear malformations and auditory neuropathy were diagnosed in 10.8% and 3.5% of probands, respectively. In 3.8% of prelingual/perilingual cases, Waardenburg syndrome was clinically diagnosed, and in 71.4%, these diagnoses were confirmed with pathogenic variants revealed; seven out of them were novel, including one CNV. All these genetic screening strategies revealed causative variants in 16.2% of the cases. Based on causative variants in the molecular diagnosis and genealogy analyses, a probable genetic etiology was found in ~ 50% of the cases. The present study highlights the relevance of GJB2/GJB6 as a cause of hearing loss in all Brazilian regions and the importance of screening unselected samples for estimating frequencies. Moreover, when a comprehensive screening is not available, molecular diagnosis can be enhanced by selecting probands for specific screenings.